|
ME group (N=68) |
Control group (N=68) |
p |
Age (years) |
50.5 ± 16.3 |
51.9 ± 17.2 |
0.628 |
Male sex |
41 (60.3%) |
35 (51.5%) |
0.388 |
Hypertension |
17 (25.0%) |
20 (29.4%) |
0.700 |
Diabetes |
7 (10.3%) |
9 (13.2%) |
0.790 |
Heart failure |
2 (2.9%) |
2 (2.9%) |
1.000 |
Coronary artery disease |
1 (1.5%) |
2 (2.9%) |
1.000 |
Atrial fibrillation |
4 (5.9%) |
3 (4.4%) |
1.000 |
Stroke |
2 (2.9%) |
2 (2.9%) |
1.000 |
Diagnosis |
|
|
|
AVNRT |
38 (55.9%) |
38 (55.9%) |
|
AVRT/WPW |
30 (44.1%) |
30 (44.1%) |
|